Supriya Lifeciences Episodic Pivot TradeSupriya Lifesciences made a gap up (episodic pivot) on 8th Feb due to its blockbuster earnings, intresting part is even in the carnage of Smallcap & Midcaps the gap has been sustained continuously for 3 consecutive days, and never did it break the low of the EP candle. This shows strength in the scrip and I believe in the coming days once the market recovers, this scrip will move easily towards 400, 440 zone.
Stoploss 312
DISCLAIMER*
This analysis is only for educational purpose. I am not a SEBI Registered Analyst/Advisor. Please consult your financial advisor before taking any position and please use a Stop Loss for any Investments/Trading Positions. It is your hard earned money so give risk management your highest attention. Do take this disclaimer seriously.
Episodicpivot
ZFSTEERING looking strongZFSTEERING after giving an episodic pivot gap with high volume is nicely respecting the gap and following tightly with respect to 21 EMA and 50 day MA. Looks like there's more gasoline left in the scrip. Stoploss should be placed ar 590-585. This is a great candidate for a swing trade.
*DISCLAIMER*
This analysis is only for educational purpose. I am not a SEBI Registered Analyst/Advisor. Please consult your financial advisor before taking any position and please use a Stop Loss for any Investments/Trading Positions. It is your hard earned money so give risk management your highest attention. Do take this disclaimer seriously.
MEDPLUS Episodic Pivot Trade IdeaMEDPLUS had an episodic pivot and gave a good retracement near its previous support and now is clearly respecting its 50 day moving average which is a clear indicator of strength in the scrip. Good opportunity to go long.
*DISCLAIMER*
This analysis is only for educational purpose. I am not a SEBI Registered Analyst/Advisor. Please consult your financial advisor before taking any position and please use a Stop Loss for any Investments/Trading Positions. It is your hard earned money so give risk management your highest attention. Do take this disclaimer seriously.